TF and pulmonary arterial hypertension: More importantly, we found that the SMAD2 TF, which is activated through TGFβ, is strongly active in PAH (Fig. 5e), thus suggesting a miss-regulation of the TGFβ pathway in the endothelial cells of PAH patients.